Variants for ADRA1A (rs2229126, TA) were only identified in individuals with pulmonary edema in the heterozygous state (Fig 1), which implies that life-threatening toxicity could occur following ritodrine use in homozygous ADRA1A variant carriers. The gene discussed is ADRA1A; the disease is edema.